June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Uncoupling caspase 8-mediated-apotosis from caspase 8-mediated-inflammation in glaucoma
Author Affiliations & Notes
  • Yinjie Guo
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Maleeka Shrestha
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Ann Marshak-Rothstein
    Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
  • Meredith S Gregory-Ksander
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Yinjie Guo None; Maleeka Shrestha None; Ann Marshak-Rothstein None; Meredith Gregory-Ksander ONL Therapeutics, Code C (Consultant/Contractor)
  • Footnotes
    Support  R21-EY030276
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1610 – A0433. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yinjie Guo, Maleeka Shrestha, Ann Marshak-Rothstein, Meredith S Gregory-Ksander; Uncoupling caspase 8-mediated-apotosis from caspase 8-mediated-inflammation in glaucoma. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1610 – A0433.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal ganglion cell (RGC) apoptosis is the common endpoint in glaucoma and both the intrinsic and extrinsic apoptotic pathways have been implicated in human and experimental models of glaucoma. However, caspase 8, which is central to the extrinsic pathway of apoptosis has been linked to both RGC apoptosis, as well as glial activation, and neuroinflammation. The recent development of a caspase 8 mutant mouse (Casp8DA/DA) in which a point mutation in the auto-cleavage site blocks caspase 8-mediated apoptosis but does not block caspase 8-mediated inflammation, allows us to uncouple the two pathways and determine the extent to which caspase 8-mediated inflammation and/or apoptosis contributes to the death of RGCs in glaucoma.

Methods : Intracameral injection of magnetic microbeads (control: saline) was used to elevate the intraocular pressure (IOP) in three groups of mice: WT mice (positive control, RGC apoptosis); Fas deficient Faslpr mice (negative control, no RGC apoptosis); Casp8DA/DA mutant mice (experimental, no extrinsic apoptosis). IOP was monitored by rebound tonometry. At 5 weeks post microbead injection, visual acuity was measured by optomotor reflex (OMR) and RGC function was assessed by pattern ERG (pERG). Retina and optic nerves were processed for RGC and axon quantification.

Results : Rebound tonometry showed equal elevation of IOP in microbead-injected WT, Faslpr, and Casp8 DA/DA mice as compared to saline controls. At 5 weeks post microbead injection, as compared to saline controls, a significant reduction in both visual acuity and pERG was observed in WT mice (pos. control), which correlated with a significant loss of RGCs and axons. By contrast, no significant reduction in visual acuity or pERG, nor loss of RGCs and axons was observed in Faslpr mice (neg. control). The Casp8DA/DA mice, in which the extrinsic apoptotic pathway is blocked, displayed a significant reduction in visual acuity and pERG equal to that observed in WT mice and, as in WT mice, this loss of function correlated with a significant loss of RGCs and axons.

Conclusions : Our data shows that the caspase 8-mediated extrinsic pathway of apoptosis is not required for the death of RGCs and loss of visual function in a microbead-induced mouse model of glaucoma, indicating that caspase 8-mediated inflammation, but not apoptosis is the driving force in the development of glaucoma.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×